Clinical trial
Etrasimod as Primary and Secondary Prevention of Pouchitis (ESPIRIT)
NCT07486921 is registered in ClinicalTrials.gov with Maia Kayal as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Etrasimod as Primary and Secondary Prevention of Pouchitis (ESPIRIT)
- Lead sponsor
- Maia Kayal
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- July 1, 2026
- Completion date
- February 6, 2030
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.